Background. The chronic recommendation of pediatric drugs could exhibit erosive and cariogenic problems.Objective. To evaluate the effects of different pediatric drugs on the color stability of various restorative materials.Methods. Five specimens (1 mm × 3 mm) were prepared and immersed in ten different pediatric drugs and agitated every 8 hours daily for 2 min up to 1 week. Between immersion periods, the samples were stored in artificial saliva. After 1-week period,ΔE⁎values were calculated. Two-way ANOVA and Fisher’s LSD test were used for statistical analysis at a level ofp<0.05.Results.ΔE⁎values were only significantly influenced by restorative material factorp<0.001and varied in the range of 2.08 and 6.55 units for all drugs/restorative materials. The highestΔE⁎was found in Ferrosanol B-composite(6.55±1.38)and the lowest one was found in Dolven-glass ionomer(2.08±0.40)pairwise. The most prominentΔE⁎value elevations were obtained in composite material compared to the compomer and/or glass ionomers in Macrol, Ferrosanol B, and Ventolin (p<0.001; for all) and also for other drugsp<0.05. Dolven exhibited significantly higher values compared to Augmentinp=0.021, Macrolp=0.018, and Ventolinp=0.013in compomer group.Conclusion. The clinically perceptible color changes for tested composite/pediatric drug pairwise can be more problematic than compomer and glass ionomers in pediatric dentistry.

Changes in the color of the teeth are a common dental finding associated with clinical and esthetic problems. Especially, the discoloration of primary teeth can cause parental concern and have a negative effect on social interactions between preschool children. The aim of the study was to evaluate the effect of pediatric drugs and an oral rinse on the discoloration of primary teeth. Similar to medication intake recommendations, 7 primary teeth in each group were immersed for 1 min in one of 11 different solutions at 8-hour intervals for 1 week. The color values were obtained using a spectrophotometer (VITA EasyShade®) at baseline and after 1 week. The color change (ΔE*) values were calculated according to the CIELab system. The statistical analysis was conducted using the one-way analysis of variance (ANOVA) and Tukey's post hoc tests at a p-value <0.05. When comparing values L*, a* and b* at baseline and day 7, a statistically significant difference was found in the a* value for the teeth immersed in pseudoephedrine (p = 0.012). There were also statistically significant differences with regard to color change at day 7 (ΔE*7) between the pseudoephedrine and chlorhexidine as well as pseudoephedrine and control groups (p = 0.034 and p = 0.030, respectively). The ΔE*7 value for pseudoephedrine was 3.7 after 1 week, indicating that it may have the potential to cause significant tooth discoloration when used for a long period. Clinicians and children's families should be aware of the fact that some pediatric drugs can cause tooth discoloration.

Dental erosion is considered one of the oral cavity diseases. Frequent intake of liquid oral medications can be an effective factor in tooth erosion. This study aimed to evaluate the effects of frequently prescribed pediatric drugs on the permanent dental enamel microhardness over a period of 14 days in vitro. In this study, 11 pediatric drugs with different active ingredients were used; the control group consisted of teeth immersed in distilled water. The immersion cycles were applied 3 times a day for 1 min. The measurements of the samples prepared were taken at 0 (baseline), 7 and 14 days after the immersion cycles using a Vickers hardness testing machine. The pH, titratable acidity (TA) and buffering capacity of the syrups were assessed. The measurements of the tooth samples that were immersed in drug solutions except Deltacortril® showed that there was a significant difference between days 0, 7 and 14. The microhardness values for the tooth samples that were immersed in the Deltacortril drug solution decreased, but no significant difference was found. There were no statistically significant differences between the day 0, 7 and 14 measurements in the control group. Commonly used and prescribed pediatric drugs pose a risk for tooth erosion. Pediatricians should be aware of the effects of prescription drugs on erosion, and stress the need for compliancy with oral hygiene procedures.

Aim: This study aimed to assess the validity and reliability of the Turkish version of the Abeer Children Dental Anxiety Scale (ACDAS) as a tool used for the identification and treatment of anxious children. Methods: The study sample included 122 children aged ≥7 years, and the intervention consisted of implementation of the ACDAS and the Children’s Fear Survey Schedule-Dental Subscale (CFSS-DS) by the lead researcher during the first dental visit for each child. ACDAS application was also repeated by another pediatric dentist in a smaller sub-sample of 20 children during the same visit. The lead researcher repeated the process, (i.e. application of ACDAS) in the whole study sample after two weeks. Results: The mean age of the participants was 9.84 ± 1.696 years (range: 7–12 years), and anxiety (ACDAS ≥ 26) was detected in 36.1% of the children. The Turkish version of the ACDAS exhibited high correlation with the CFSS-DS (r = 0.760; p < 0.001), and the Cronbach Alpha value (α = 0.934) showed good internal consistency. No statistically significant differences were observed in the dentist’s responses to questions in the Dental and Cognitive sections when comparing the first and second applications of the scale (p > 0.05), although significant differences were observed in the Child Evaluation section (p < 0.01). The Area Under the Curve (AUC), obtained by Receiver Operative Characteristic Curve (ROC) Analysis was 0.849 indicating good diagnostic performance. Conclusions: Based on these findings, the Turkish version of the ACDAS can be considered as a valid and reliable dental anxiety scale for the identification of children concerned about dental procedures.